Amphastar Pharmaceuticals AMPH Primatenemist — Other Receivables

Similar metrics at other companies

GYREGNI — Other Receivables

$200K0.0%

BRK.BInsurance And Other — Other Receivables

$5.16B-1.5%

BRK.BRailroad Utilities And Energy — Other Receivables

$632M-7.9%

TPLOil and gas royalties — Accounts receivable and accrued receivables, net

$61.3M+1.0%

KBHHomebuilding — Other

$40.47M+32.2%

BRK.BInsurance And Other — Premiums And Other Receivables Net

$48.64B+2.4%

FAQ

What is Amphastar Pharmaceuticals's primatenemist — other receivables?

Amphastar Pharmaceuticals (AMPH) reported primatenemist — other receivables of $0 in Q2 2026.

What does primatenemist — other receivables mean?

This metric captures the outstanding amounts owed to the company specifically related to the Primatenemist product line that are not classified as standard trade accounts receivable. It often includes items such as claims, rebates, or other contractual adjustments due from distributors or group purchasing organizations. Monitoring this balance is essential for evaluating the quality of earnings and the efficiency of the company's working capital management for this specific product segment.